instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: The three have been speaking out this week as part of a high-profile “Heads Together” campaign, which aims to break stigmas around mental health issues and encourage people to speak openly about their emotions. In a six-minute film recorded at Kensington Palace in central London on Wednesday, the trio discussed the stress of becoming new parents, dealing with trauma at work, and the death of the princes’ mother, Princess Diana, in a Paris car crash in 1997. “When you have children, it really does put your own emotions and your own life into perspective and it has been very, very interesting understanding why I get so upset about some things, why some things effect me,” William said in the clip released by his office on Friday. “I thought I was fairly straight down the line, but I feel quite a lot more than I used to.”  William, Queen Elizabeth’s grandson and second in line to the throne, said he had taken home some of the cases he had encountered when working as an air ambulance helicopter pilot. He and Kate also spoke of the pressure of parenthood following the birth of son George in 2013. “... You have no idea what you’re doing no matter how many books you read - nothing can prepare you for it,” Kate said. The first few weeks after they returned to their former home in Wales, she said, “were a steep learning curve, massively”. Earlier this week, William talked about how the shock of losing his mother still lingered 20 years after her death. Harry said he had sought counseling to help deal with the grief. William warned the British virtue of the stiff upper lip could damage mental health - a departure from the royal family’s traditional stoic attitude amid crises ranging from the 1936 abdication of King Edward VIII to the death of Princess Diana. “We have been brought closer because of the circumstances. You are uniquely bonded because of what we’ve been through. But even Harry and I over the years have not talked enough about our mother,” William said. Harry added: “Never enough”. “I always thought to myself, ‘what’s the point in bringing up the past?’,” Harry said. “What’s the point in bringing up something that’s only going to make you sad, it ain’t going to change it, it ain’t going to bring her back. When you start thinking like that, it can be really damaging.”  A Kensington Palace spokesman said the royals had been overwhelmed by the response to their campaign. “Having asked others to start conversations on mental health with their friends and families, they wanted to show that they are taking part as well,” the spokesman said. Claim: UK's William, Harry and Kate open up about emotional struggles.
answer:
Britain’s Prince William, his wife Kate and brother Harry have given their most public comments on their emotional struggles and how the siblings’ closeness helped them cope with their mother’s death.


question:
Paragraph: Democrats on a subcommittee of the House of Representatives Committee on Oversight and Reform released a cache of internal Juul emails and other documents that committee staff described as early attempts to “enter schools and convey its messaging directly to teenage children.”   Juul’s use of social media influencers to promote its vaping devices in the years after it launched in 2015 also came under scrutiny. James Monsees, Juul’s co-founder and chief product officer, told the committee that the company’s target audience from the beginning has been adult cigarette smokers. Among efforts cited in the Juul documents released were a $134,000 payment to set up a five-week “holistic health education” summer camp at a Maryland charter school, recruiting children from third through 12th grades, and offering $10,000 to schools using the company’s “youth prevention and education” programs for students, including those caught using e-cigarette products. “You don’t think that sounds strange at all?” Representative Katie Hill, a Democrat, asked Juul’s chief administrative officer, Ashley Gould. “All of these educational efforts were intended to keep youth from using the product,” Gould responded. When Juul realized how the school involvement could be perceived as negative, “we stopped the program,” she said. In a statement after the hearing, Juul said the $134,000 donation was to “facilitate already-existing community outreach and youth-prevention programs,” and said the company “did not have any direct interaction with the students.”  Several committee members said Juul’s initiatives appeared similar to past efforts by the tobacco industry to reach young people under the guise of smoking prevention programs. Gould said Juul, which is 35 percent owned by Marlboro maker Altria Group Inc (MO.N), halted its program last year once it became aware of the tobacco industry’s past moves. Caleb Mintz, 17, a New York city high school student, testified at a separate hearing on Wednesday that a Juul representative came to his school as part of an educational program on mental health and addiction last year. He said in an interview Thursday that students received “mixed messages” about the product, being told it was safe but not to buy it. Mintz said after the hearing that the Juul presentation seemed to be “playing to the side of teens as rebellious. When a teen is told not to do something, they’re more likely to do it.”    Members of the committee also quizzed Gould and Monsees over the use of social media influencers to promote Juul’s vaping devices. Company executives early on agreed that “younger consumers age 25 to 34 was going to be the target of our initial campaign,” Monsees said. “They would be more receptive to new technology solutions,” such as the Juul device. Amid an enormous uptick in teenage use of e-cigarettes in 2018 — a 78% increase among high school students from 2017 to 2018, according to federal data — Juul said it ended all social media advertising last fall. Juul also pulled many flavored nicotine pods, except mint, menthol and tobacco, from retail stores, which Monsees said represented more than half of the company’s sales at that time. Claim: U.S. lawmakers grill e-cigarette maker Juul over efforts targeted at schoolchildren.
answer:
E-cigarette maker Juul Labs Inc funded a “holistic health education” camp as part of efforts to market directly to school-aged children, members of a U.S. congressional panel said on Thursday, citing internal company documents.


question:
Paragraph: Currently the drug, Vascepa, is approved for a relatively narrow group of patients with extremely high levels of triglycerides, a type of fat in the blood linked to heart disease. Irish drugmaker Amarin is seeking approval for a much larger group of patients who have lower fat levels but are still at risk of heart problems, despite taking cholesterol-lowering statin drugs like Lipitor and Zocor. The panel of advisers to the Food and Drug Administration unanimously supported the expansion based on recent study results showing the drug can cut rates of life-threatening heart problems in high-risk patients. “There is no doubt this drug could benefit a substantial portion of the U.S. population and meet an unmet need,” said Dr. Jack Yanovski, a panelist and hormone specialist from the federal National Institutes of Health. The FDA is not required to follow the group’s advice and is expected to make its decision by the end of the year. Financial analysts predict that broader use could translate into billions in sales for Amarin. Vascepa costs around $300 a month. Some panelists urged the FDA to tailor the drug’s label to patients who are most likely to benefit. “I do not want to see this become what I call cardio candy,” said Philip Posner, a patient representative on the panel. FDA-written drug labels guide physician prescribing and often determine which uses are paid for by insurers. Panelists based their decision on a company-funded study showing that Vascepa cut the risk of heart attack, clogged arteries and other cardiovascular problems by about 25%, compared with a dummy treatment. Patients in the study were randomly assigned to take Vascepa or mineral oil capsules as a comparison. Patients in the trial had high triglycerides and other risk factors for heart problems, such as diabetes. The results, published last year, came as a surprise because a string of past studies of fish oil failed to show a positive impact on heart health. The panel noted several potential side effects of the drug, including irregular heartbeats and internal bleeding. But they agreed the drug’s benefits outweighed those risks, which could be monitored and managed by physicians. Millions of Americans take over-the-counter fish oil supplements for their presumed health benefits. These oils, also called omega-3 fatty acids, are known to reduce triglycerides. But several pharmaceutical trials have tried and failed to show that lowering those fats translates into meaningful benefits for patients. If approved, Vascepa would be the first fat-lowering drug endorsed by the FDA to reduce heart problems. Amarin has long tried to differentiate its drug from non-prescription fish oil supplements. Company advertising states that it can take 10 to 40 over-the-counter capsules to equal the daily dose of Vascepa. The drug is taken in four 1-gram capsules per day. Wall Street analysts have high expectations for broader use of the drug, with some projecting annual sales of $3 billion or higher. That compares to total company sales of just $228.4 million in 2018, according to Amarin’s financial reports. Vascepa, first approved in 2012, is Amarin’s only product on the U.S. market. ___ Follow Matthew Perrone on Twitter: @AP_FDAwriter ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content. Claim: US panel backs wider use of fish oil to prevent heart attack.
answer:

Government health experts on Thursday recommended broader use of a prescription-strength fish oil drug to help many more patients at risk for heart attack, stroke and related health problems.